Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

Blood Exposures Survey

The Association of Occupational Health Professionals in Healthcare (AOHP) recently commissioned a survey among its members to establish the first ...read more

Food Safety in Restaurants

Increased awareness and implementation of proper food safety in restaurants and delis may help prevent many of the foodborne illness outbreaks ...read more

Flu Facts

The Centers for Disease Control and Prevention (CDC) provides Frequently Asked Questions (FAQs) on key facts about the 2013-2014 influenza season. ...read more

SSI Prevention

This report explores the prevention of surgical site infections (SSIs) within the context of evidence-based practices replacing "sacred cows" in the ...read more

Biocides and Sporicidal Disinfectants

This Pulse provides a quick summary of some of the ideas and perspectives coming out of the 2013 Spring Conference of the Society of Healthcare ...read more

Latest Headlines

Sterion Incorporated Announces Sale of Sterilization Container Product Line to STERIS Corporation

MINNEAPOLIS, and MENTOR, Ohio -- Sterion Incorporated and STERIS Corporation announced that Sterion has sold certain sterilization container assets to STERIS for $2.9 million in cash. The Sterion Sterilization Container System offers healthcare personnel a simple and ...More
May 13, 2003 Posted in News, Disinfection & Sterilization
Clinical Study Finds that PerioChip is an Effective and Safe Treatment Option for the Long-Term Management of Chronic Periodontitis

EDISON, N.J. -- A recent study has shown that the long-term use of PerioChip as an adjunct to a routine periodontal maintenance program in patients with periodontal disease is both safe and effective. Routine periodontal maintenance is a therapeutic option among dentists ...More
May 13, 2003 Posted in News
InterMune Announces Potent Antibiotic Activity of Oritavancin in In Vitro Studies Presented at ECCMID; Potency Against Resistant Bacterial Strains May Make Agent Important for Hospital Market

GLASGOW, Scotland and BRISBANE, Calif. -- InterMune, Inc. has announced that in vitro studies of its novel antibiotic, oritavancin, demonstrate its potent activity against European isolates of susceptible and resistant strains of Staphylococcus, Streptococcus and ...More
May 13, 2003 Posted in News
IPM Hails Global HIV Prevention Working Group's Call for $1 Billion in Additional Public-Sector Spending on Microbicide R & D

SILVER SPRING, Md. -- The International Partnership for Microbicides (IPM) endorsed the Global HIV Prevention Working Group's new report calling for $3.8 billion in additional annual spending by 2005 for existing prevention programs. IPM said it is especially pleased that ...More
May 13, 2003 Posted in News
SARS and Plumbing: The Role Sewage Plays in Spreading Disease

CINCINNATI -- Recent reports by the World Health Organization (WHO) have shed new light on the role sewage plays in spreading the deadly disease known as severe acute respiratory syndrome, or SARS. The issue emerged following a SARS outbreak at the Amoy Garden apartment ...More
May 13, 2003 Posted in News, PPE & Standard Precautions
Pressure Combined with Heat Reduces Prion Infectivity in Processed Meats

WASHINGTON -- The combination of high temperature and very high pressure in the preparation of processed meats such as hot dogs and salami may effectively reduce the presence of infective prions while retaining the taste, texture, and look of these meats, according to a ...More
May 13, 2003 Posted in News
IDSA Urges Congress Not to Shortchange Infectious Disease Programs

:IDSA Urges Congress Not to Shortchange Infectious Disease Programs @bodyWASHINGTON, D.C. -- The Infectious Diseases Society of America (IDSA) today urged Congress to fund federal infectious diseases programs at levels that are sufficient to protect the public from emerging ...More
May 13, 2003 Posted in News
Stryker Howmedica Osteonics Receives FDA Clearance for Simplex P With Tobramycin Antibiotic Bone Cement

KALAMAZOO, Mich. -- Stryker Corporation announces that its orthopaedic implant division, Stryker Howmedica Osteonics, received clearance from the Food and Drug Administration (FDA) to begin marketing and selling Simplex P with Tobramycin Bone Cement in the United States. ...More
May 13, 2003 Posted in News
Group Says FDA and CDC are Bumbling at the Expense of Mercury-Poisoned Children

WASHINGTON -- The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are not protecting children from the hazards of mercury poisoning, charges The Autism Autoimmunity Project. The group reports the House Government Reform Committee ...More
May 13, 2003 Posted in News
Vicuron Announces Positive Phase II Data With Anidulafungin in Most Common Hospital Fungal Infections Presented at ECCMID Meeting

GLASGOW, Scotland and KING OF PRUSSIA, Pa. -- Vicuron Pharmaceuticals announced today that positive results from a large Phase II study highlighting anidulafungin, its lead product candidate, as a potential therapy for invasive candidiasis (IC)/candidemia, the most common ...More
May 13, 2003 Posted in News